Use of Midostaurin in Mixed Phenotype Acute Leukemia with FLT3 Mutation: A Case Series. Tremblay Z, Wong A, Otis AS, Pepin MA, et al. Eur J Haematol 2021 Oct 15. doi: 10.1111/ejh.13717.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Tremblay Z, Wong A, Otis AS, Pepin MA, et al. Use of Midostaurin in Mixed Phenotype Acute Leukemia with FLT3 Mutation: A Case Series. Eur J Haematol 2021 Oct 15. doi: 10.1111/ejh.13717.
PMID: 34653270